Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Castoldi, Mirco ^a   Kordes, Claus ^a   Sawitza, Iris ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ANIMAL; BLOOD; GENETICS; INFLAMMATION; ISOLATION AND PURIFICATION; LIVER RESECTION; MALE; MEMBRANE MICROPARTICLE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; CELL-DERIVED MICROPARTICLES; HEPATECTOMY; INFLAMMATION; MALE; MICRORNAS; RATS; RATS, WISTAR;

EID: 84983344340     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31869     Document Type: Article

References (61)

1. Chim, S. S., et al. Detection and Characterization of Placental MicroRNAs in Maternal Plasma. Clin Chem 54, 482-90 (2008).
2. Dimmeler, S. & Zeiher, A. M. Circulating microRNAs: novel biomarkers for cardiovascular diseases? European heart journal 31, 2705-7 (2010).
3. Gupta, S. K., Bang, C. & Thum, T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 3, 484-8 (2010).
4. Fichtlscherer, S., et al. Circulating microRNAs in patients with coronary artery disease. Circulation research 107, 677-84 (2010).
5. Neal, C. S., et al. Circulating microRNA expression is reduced in chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 26, 3794-802 (2011).
6. Bala, S., et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56, 1946-57 (2012).
7. Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N. & Beretta, L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PloS one 6, e23937 (2011).
8. Ji, F., et al. Circulating microRNAs in hepatitis B virus-infected patients. Journal of viral hepatitis 18, e242-51 (2011).
9. Gailhouste, L., Gomez-Santos, L. & Ochiya, T. Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. Frontiers in bioscience 18, 199-223 (2013).
10. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L. & Turbide, C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). The Journal of biological chemistry 262, 9412-20 (1987).
11. Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nature reviews. Immunology 2, 569-79 (2002).
12. Barteneva, N. S., et al. Circulating microparticles: square the circle. BMC Cell Biol 14, 23 (2013).
13. Mause, S. F. & Weber, C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation research 107, 1047-57 (2010).
14. Crescitelli, R., et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2 (2013).
15. Zernecke, A., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science signaling 2, ra81 (2009).
16. Gyorgy, B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68, 2667-88 (2011).
17. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011).
18. Arroyo, J. D., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108, 5003-8 (2011).
19. Turchinovich, A. & Burwinkel, B. Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA biology 9, 1066-75 (2012).
20. Wang, K., Zhang, S., Weber, J., Baxter, D. & Galas, D. J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic acids research 38, 7248-59 (2010).
21. Taylor, D. D. & Shah, S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods 87, 3-10 (2015).
22. Mittelbrunn, M., et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nature communications 2, 282 (2011).
23. Turchinovich, A., Weiz, L., Langheinz, A. & Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233 (2011).
24. Mehdiani, A., et al. An innovative method for exosome quantification and size measurement. J Vis Exp 50974 (2015).
25. El-Hefnawy, T., et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clinical chemistry 50, 564-73 (2004).
26. Rykova, E. Y., et al. Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Annals of the New York Academy of Sciences 1075, 328-33 (2006).
27. Benes, V., et al. Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci Rep 5, 11590 (2015).
28. Marquez, R. T., Wendlandt, E., Galle, C. S., Keck, K. & McCaffrey, A. P. MicroRNA-21 is up-regulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol 298, G535-41 (2010).
29. Xu, J., et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50, 136-42 (2011).
30. Song, G., et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 51, 1735-43 (2010).
31. Li, L., et al. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PloS one 7, e46957 (2012).
32. Mabuchi, A., et al. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol 40, 910-6 (2004).
33. Kalinichenko, V. V., et al. Foxf1+ /- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 37, 107-17 (2003).
34. Kordes, C., Sawitza, I., Gotze, S., Herebian, D. & Haussinger, D. Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest 124, 5503-15 (2014).
35. Kordes, C., Sawitza, I. & Haussinger, D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun 367, 116-23 (2008).
36. Blindenbacher, A., et al. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38, 674-82 (2003).
37. Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic oncology 110, 13-21 (2008).
38. Rabinowits, G., Gercel-Taylor, C., Day, J. M., Taylor, D. D. & Kloecker, G. H. Exosomal microRNA: a diagnostic marker for lung cancer. Clinical lung cancer 10, 42-6 (2009).
39. Braicu, C., et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell death and differentiation 22, 34-45 (2015).
40. Pegtel, D. M., et al. Functional delivery of viral miRNAs via exosomes. Proceedings of the National Academy of Sciences of the United States of America 107, 6328-33 (2010).
41. Valadi, H., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology 9, 654-9 (2007).
42. Chevillet, J. R., et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proceedings of the National Academy of Sciences of the United States of America 111, 14888-93 (2014).
43. Zheng, J., et al. Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med 32, 17-24 (2013).
44. Venugopal, S. K., et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298, G101-6 (2010).
45. G. M., H. & R. M., A. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol Lab Med. 12, 186-202 (1931).
46. Livshts, M. A., et al. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. Sci Rep 5, 17319 (2015).
47. Gardiner, C., Ferreira, Y. J., Dragovic, R. A., Redman, C. W. & Sargent, I. L. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles 2 (2013).
48. Castoldi, M., et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 121, 1386-96 (2011).
49. Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8, R19 (2007).
50. Pattyn, F., Speleman, F., De Paepe, A. & Vandesompele, J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic acids research 31, 122-3 (2003).
51. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-8 (2001).
52. Mestdagh, P., et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10, R64 (2009).
53. Berry, M. N. & Friend, D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43, 506-20 (1969).
54. Hendriks, H. F., Verhoofstad, W. A., Brouwer, A., de Leeuw, A. M. & Knook, D. L. Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res 160, 138-49 (1985).
55. Landgraf, P., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-14 (2007).
56. Bala, S., et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 286, 1436-44 (2011).
57. Cirera-Salinas, D., et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 11, 922-33 (2012).
58. Ng, R., Song, G., Roll, G. R., Frandsen, N. M. & Willenbring, H. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest 122, 1097-108 (2012).
59. Muller, A. H., et al. Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats. BMC Genomics 16, 119 (2015).
60. Rasmussen, K. D., et al. The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207, 1351-8 (2010).
61. Magrelli, A., et al. Altered microRNA Expression Patterns in Hepatoblastoma Patients. Transl Oncol 2, 157-63 (2009).